Hikma Pharmaceuticals has partnered with Ergomed in order for the latter to manage clinical trials involving Hikma treatments.

Signed in September 2011, the agreement will see Ergomed conduct the first clinical trials of Hikma’s key oncology products in Jordanian hospitals, which could potentially expand into the MENA region. In return, Ergomed will receive access to Hikma’s insight into the regional pharmaceutical sector.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Hikma CEO Said Darwazah heralded the partnership, saying: "Our decision to work with Ergomed comes from a strong commitment to continuous medical advancement through the use of clinical trials, especially in the field of oncology."

Ergomed CEO Miroslav Reljanovic echoed Darwazah’s sentiments before confirming that Ergomed is currently developing a full-service MENA business, which is to be managed from its head office, located in Dubai.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now